
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11625828
[patent_doc_number] => 20170136014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor and/or a JAK-2 Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 15/319740
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 164
[patent_figures_cnt] => 164
[patent_no_of_words] => 149689
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15319740
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/319740 | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor | Jun 16, 2015 | Issued |
Array
(
[id] => 11541643
[patent_doc_number] => 20170095468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'TRANSDERMAL FORMULATIONS OF PERGOLIDE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/314727
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8092
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15314727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/314727 | Transdermal formulations of pergolide and uses thereof | Jun 10, 2015 | Issued |
Array
(
[id] => 10387955
[patent_doc_number] => 20150272962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/735798
[patent_app_country] => US
[patent_app_date] => 2015-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22324
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14735798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/735798 | METHODS FOR TREATING OR PREVENTING CANCER AND NEURODEGENERATIVE DISEASES | Jun 9, 2015 | Abandoned |
Array
(
[id] => 10459384
[patent_doc_number] => 20150344398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => '4-HYDROXYBUTYRIC ACID ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 14/732859
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9352
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732859 | 4-hydroxybutyric acid analogs | Jun 7, 2015 | Issued |
Array
(
[id] => 11527133
[patent_doc_number] => 20170087110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Methods of Treating Neurodevelopmental Diseases and Disorders'
[patent_app_type] => utility
[patent_app_number] => 15/316110
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10567
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316110 | Methods of treating neurodevelopmental diseases and disorders | Jun 4, 2015 | Issued |
Array
(
[id] => 10174868
[patent_doc_number] => 09205055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/727997
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12988
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14727997
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/727997 | Controlled release hydrocodone formulations | Jun 1, 2015 | Issued |
Array
(
[id] => 11742764
[patent_doc_number] => 20170196836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Lung Cancer Adjuvant Therapy'
[patent_app_type] => utility
[patent_app_number] => 15/313339
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11209
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313339 | Lung cancer adjuvant therapy | May 26, 2015 | Issued |
Array
(
[id] => 10365755
[patent_doc_number] => 20150250760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATMENT OF OSTEOLYSIS OR PROLONGATION OF PROSTHETIC IMPLANT'
[patent_app_type] => utility
[patent_app_number] => 14/716587
[patent_app_country] => US
[patent_app_date] => 2015-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24675
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14716587
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/716587 | Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant | May 18, 2015 | Issued |
Array
(
[id] => 11668315
[patent_doc_number] => 20170157035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/714131
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16547
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714131
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714131 | Intravascular delivery of nanoparticle compositions and uses thereof | May 14, 2015 | Issued |
Array
(
[id] => 10435694
[patent_doc_number] => 20150320706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'FORMULATIONS AND METHODS OF TREATING ALZHEIMER\'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/707033
[patent_app_country] => US
[patent_app_date] => 2015-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27351
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14707033
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/707033 | FORMULATIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY | May 7, 2015 | Abandoned |
Array
(
[id] => 11721227
[patent_doc_number] => 09694073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/701321
[patent_app_country] => US
[patent_app_date] => 2015-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 12971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701321
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/701321 | Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereof | Apr 29, 2015 | Issued |
Array
(
[id] => 10353424
[patent_doc_number] => 20150238430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/699719
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3839
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14699719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/699719 | PHARMACEUTICAL COMPOSITION | Apr 28, 2015 | Abandoned |
Array
(
[id] => 11479385
[patent_doc_number] => 09585907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Methods and compositions for modulating Tau levels'
[patent_app_type] => utility
[patent_app_number] => 14/697156
[patent_app_country] => US
[patent_app_date] => 2015-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 54
[patent_no_of_words] => 30519
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14697156
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/697156 | Methods and compositions for modulating Tau levels | Apr 26, 2015 | Issued |
Array
(
[id] => 11684060
[patent_doc_number] => 09682092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Boron-containing small molecules as anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 14/688581
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 34136
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14688581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/688581 | Boron-containing small molecules as anti-inflammatory agents | Apr 15, 2015 | Issued |
Array
(
[id] => 11419836
[patent_doc_number] => 20170027979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'METHOD FOR ASSESSING AND TREATING OR PREVENTING IMPAIRED PLASMA POLAR LIPID LEVELS'
[patent_app_type] => utility
[patent_app_number] => 15/303592
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21104
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303592 | Method for assessing and treating or preventing impaired plasma polar lipid levels | Apr 13, 2015 | Issued |
Array
(
[id] => 12211060
[patent_doc_number] => 09907852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Anticancer agent and side-effect-alleviating agent'
[patent_app_type] => utility
[patent_app_number] => 15/302863
[patent_app_country] => US
[patent_app_date] => 2015-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 15100
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/302863 | Anticancer agent and side-effect-alleviating agent | Apr 9, 2015 | Issued |
Array
(
[id] => 11722362
[patent_doc_number] => 09695209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins'
[patent_app_type] => utility
[patent_app_number] => 15/303039
[patent_app_country] => US
[patent_app_date] => 2015-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 13350
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303039 | Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins | Apr 7, 2015 | Issued |
Array
(
[id] => 11656014
[patent_doc_number] => 09668994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Methods and compositions for increasing the anaerobic working capacity in tissues'
[patent_app_type] => utility
[patent_app_number] => 14/673556
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 11747
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14673556
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/673556 | Methods and compositions for increasing the anaerobic working capacity in tissues | Mar 29, 2015 | Issued |
Array
(
[id] => 10311564
[patent_doc_number] => 20150196567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 14/671151
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 109238
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/671151 | ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT | Mar 26, 2015 | Abandoned |
Array
(
[id] => 11512874
[patent_doc_number] => 20170079948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'COMPOSITIONS AND METHODS TO TREAT NIEMANN-PICK DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/126339
[patent_app_country] => US
[patent_app_date] => 2015-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5090
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/126339 | Compositions and methods to treat Niemann-Pick disease | Mar 26, 2015 | Issued |